ENTITY

Relypsa Inc (RLYP US)

Health Care • United States

Relypsa, Inc. operates as a pharmaceuticals company. The Company develops and markets non-absorbed polymeric drugs to treat renal, cardiovascular, and metabolic diseases.

Refresh

Focused

No publications yet

There aren’t any syndicated reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00